Aldeyra Therapeutics, Inc.ALDXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-60.12M
↓ 46% below average
Average (9y)
$-41.24M
Historical baseline
Range
High:$-11.99M
Low:$-63.07M
CAGR
+19.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-60.12M | -40.5% |
| 2023 | $-42.79M | +31.7% |
| 2022 | $-62.68M | -11.5% |
| 2021 | $-56.22M | -62.2% |
| 2020 | $-34.67M | +45.0% |
| 2019 | $-63.07M | -58.9% |
| 2018 | $-39.70M | -76.5% |
| 2017 | $-22.49M | -20.3% |
| 2016 | $-18.70M | -55.9% |
| 2015 | $-11.99M | - |